ICU acquired weakness Clinical Trials

12 recruitingLast updated: May 11, 2026

There are 12 actively recruiting icu acquired weakness clinical trials across 8 countries. Studies span Not Applicable. Top locations include Birmingham, Alabama, United States, Columbus, Ohio, United States, Lexington, Kentucky, United States. Updated daily from ClinicalTrials.gov.


ICU acquired weakness Trials at a Glance

12 actively recruiting trials for icu acquired weakness are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Birmingham, Columbus, and Lexington. Lead sponsors running icu acquired weakness studies include Asan Medical Center, Centre Hospitalier Régional d'Orléans, and Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil.

Browse icu acquired weakness trials by phase

Treatments under study

About ICU acquired weakness Clinical Trials

Looking for clinical trials for ICU acquired weakness? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ICU acquired weakness trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ICU acquired weakness clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

Cardiorespiratory FitnessICU acquired weaknessCOVID-19+2 more
Duke University120 enrolled5 locationsNCT05218083
Recruiting
Not Applicable

Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge

ICU Acquired Weakness (ICUAW)
Asan Medical Center70 enrolled1 locationNCT07489092
Recruiting
Not Applicable

Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )

ICU acquired weaknessMetabolic DisturbanceQuality of Life+3 more
Technical University of Munich40 enrolled4 locationsNCT05919940
Recruiting
Not Applicable

Behavioral Economic & Staffing Strategies in the ICU

ICU acquired weaknessPainMechanical Ventilation Complication+3 more
University of Nebraska8,100 enrolled3 locationsNCT06184945
Recruiting
Not Applicable

Effect of the "Sitting Out of Bed in an Arm-chair Position" in ICU on Functional Recovery Among Ventilated Patients

ICU acquired weakness
Centre Hospitalier Régional d'Orléans150 enrolled11 locationsNCT06973746
Recruiting

ICU Combined Assessment of Cardio-Respiratory Exercise

ICU acquired weaknessmicrocirculationSepsis+2 more
University of Manitoba50 enrolled1 locationNCT06193980
Recruiting

Muscle Recovery After Critical Illness

ICU acquired weaknessMuscle WeaknessCritical Illness+1 more
Kirby Mayer209 enrolled3 locationsNCT05537298
Recruiting

Predictive Validity of the Chelsea Critical Care Physical Assessment Tool (CPAx) for Regaining Autonomy Three Months After ICU Discharge

ICU acquired weaknessIntensive Care Neuropathy
Centre Hospitalier Intercommunal Elbeuf-Louviers-Val de Reuil25 enrolled1 locationNCT07167121
Recruiting
Not Applicable

ICU-Recover Box 2.0, Smart Technology for Home Monitoring of ICU Patients

ICU acquired weakness
Leiden University Medical Center50 enrolled1 locationNCT07162948
Recruiting
Not Applicable

Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)

ICU acquired weaknessMalnutritionCritical Illness
HEIDEGGER CP164 enrolled1 locationNCT05865314
Recruiting
Not Applicable

Feasibility and Safety of Digital Rehab Platform for Bedridden Patients

ICU Acquired Weakness (ICUAW)
Asan Medical Center20 enrolled1 locationNCT06849765
Recruiting
Not Applicable

Hand and Arm Rehabilitation Using VR

ICU acquired weaknessPost-Intensive Care Syndrome
Frisius Medisch Centrum108 enrolled1 locationNCT06373341